Pay in 4 interest-free payments of $6.15 Learn more
Ships within 48 hours · Estimated delivery Nov 12 - Nov 17
Lawsuits claim the manufacturer knew or should have known about these risks and failed to adequately warn patients and doctors, forming the basis for failure to warn legal claims
Beilstein/REAXYS Number: 1718700
The body is more complex than that
Commercial patch safety concerns Without clinical trials or regulatory oversight, the safety profile of commercial patches is largely unknown: Ingredient quality : No verification of purity or potency Skin reactions : Adhesives and ingredients may cause irritation or allergic responses Interactions : Herbal components like berberine may interact with medications Undisclosed ingredients : Some patches may contain undeclared substances The MHRA doesnt evaluate these products before they reach the market, and adverse events arent systematically collected or reviewed
Presented for research literature review only Stradaioli G et al
